BD 275005 - Macro-Vue RPR Card Test Kit #110, Qualitative 500 Tests Rapid Plasma Reagin Test for Syphilis Screening, EA

BD 275005 - Macro-Vue RPR Card Test Kit #110, Qualitative 500 Tests Rapid Plasma Reagin Test for Syphilis Screening, EA

The BD 275005 - BD BBL Macro-Vue RPR Card Test Kit #110 (500 Count) is a qualitative diagnostic assay used for the detection of reagin antibodies associated with syphilis infection. Manufactured by Becton Dickinson (BD) under the BBL Macro-Vue brand, this test employs the Rapid Plasma Reagin (RPR) flocculation method for efficient and accurate screening of Treponema pallidum infections. The kit is designed for use in clinical laboratories, hospitals, and public health screening programs requiring dependable, high-throughput syphilis testing.

Each BD Macro-Vue RPR Card Test Kit provides all essential reagents and materials for performing qualitative screening of serum or plasma samples. The test detects non-treponemal antibodies (reagins) that appear during both primary and secondary stages of syphilis infection, making it a valuable tool in diagnostic and epidemiological applications.

Key Benefits

The BD Macro-Vue RPR Card Test Kit is trusted globally for its reliability, simplicity, and performance. Key advantages include:

• Rapid results: Provides accurate qualitative results within minutes, enabling same-day screening.
• High sensitivity and specificity: Detects reagin antibodies with excellent correlation to confirmatory treponemal tests.
• Easy-to-use format: Requires minimal equipment and technical expertise for interpretation.
• Large testing capacity: 500-test kit ideal for high-volume laboratories and screening centers.
• Clear visualization: Flocculation pattern easily observed on a black testing card under adequate lighting.
• Validated performance: Complies with FDA and CDC recommendations for non-treponemal syphilis testing.

Compatibility and Applications

The BD 275005 Macro-Vue RPR Test Kit is suitable for use in laboratories performing serologic screening for syphilis. It is compatible with routine diagnostic workflows and applicable in:

• Hospital and clinical laboratory testing for Treponema pallidum infection.
• Public health and community-based syphilis screening programs.
• Blood bank donor testing (for initial screening, not confirmatory diagnosis).
• STD and sexual health clinics performing point-of-care diagnostic testing.
• Research and epidemiological surveillance studies.

This kit is designed for qualitative determination but may be used in conjunction with semi-quantitative methods to assess disease progression or response to therapy.

Usage Guidelines

Perform the test according to BDs official product insert instructions. In brief:

• Allow reagents and specimens to reach room temperature (2025C) before testing.
• Add one drop of patient serum or plasma to the designated circle on the test card.
• Add one drop of the RPR antigen suspension using the provided pipette.
• Rotate the card gently for 8 minutes at 100 2 rpm.
• Observe for black clumping (flocculation) under a light source.

A reactive (positive) result is indicated by visible flocculation, while a non-reactive result shows no clumping. Reactive results should be confirmed using a treponemal-specific test such as FTA-ABS or TP-PA.

Certifications, Safety Standards, and Regulatory Approvals

The BD BBL Macro-Vue RPR Card Test Kit is FDA-cleared and CE-marked for in vitro diagnostic (IVD) use. It is manufactured under ISO 13485:2016-certified quality management systems and validated according to CLSI and CDC reference procedures. The product complies with all applicable CLIA and WHO guidelines for syphilis screening assays. Each lot is quality-tested for reagent stability, sensitivity, and negative/positive control reactivity.

Comparison with Competitor Products

Compared to other RPR test kits on the market, the BD Macro-Vue #110 delivers superior performance consistency, reagent stability, and clarity of endpoint visualization. Competitor kits may require additional preparation steps or exhibit reduced reagent shelf life. BDs ready-to-use reagents and well-calibrated controls ensure reliable interpretation and consistent accuracy, even in high-volume testing environments. The included control sera further enhance confidence in test validity and reproducibility.

Typical User Profile and Application Scenarios

This product is designed for use by qualified laboratory personnel, clinical technologists, and healthcare professionals in:

• Clinical laboratories performing diagnostic syphilis testing.
• Public health screening facilities conducting large-scale population testing.
• STD and reproductive health clinics offering rapid point-of-care testing.
• Hospital laboratories monitoring patients with suspected or confirmed syphilis infections.

The BD Macro-Vue RPR Kit is especially valuable for high-throughput testing environments where speed, reliability, and accuracy are critical.

Best Practices for Use and Maintenance

Store reagents at 28C. Do not freeze. Protect reagents and antigen suspension from direct light and contamination. Before testing, ensure that all components have equilibrated to room temperature. Use clean, disposable pipettes for each sample to prevent cross-contamination. Dispose of all biohazardous materials following institutional and regulatory guidelines. Do not use expired reagents, and always run control tests with each batch to ensure assay performance integrity.

Regulatory and Safety Information

The BD 275005 - BD Macro-Vue RPR Card Test Kit is FDA-cleared for in vitro diagnostic use and conforms to WHO-recommended serologic testing standards for syphilis. It is non-toxic and safe for laboratory use under standard biosafety level 2 (BSL-2) conditions. A Safety Data Sheet (SDS) and Certificate of Analysis (CoA) are available from BD upon request, providing detailed information about reagent composition, safety measures, and performance validation data.

How to Order

To order BD 275005 - BD BBL Macro-Vue #110 Syphilis RPR Card Test Kit (Qualitative, 500 Count), add the product to your cart and complete checkout through CIA Medical. We offer competitive pricing, reliable delivery, and expert support for clinical and diagnostic laboratories. For bulk orders, Certificates of Conformance, or reagent performance documentation, contact CIA Medicals customer service team at (312) 275-5850 or use the contact form on this page. Our representatives are available to assist with product specifications, test kit availability, and storage requirements.